| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | RNA-DNA hybrid ribonuclease activity | 5.63e-12 | 11 | 35 | 5 | GO:0004523 | |
| GeneOntologyMolecularFunction | RNA-directed DNA polymerase activity | 2.43e-11 | 14 | 35 | 5 | GO:0003964 | |
| GeneOntologyMolecularFunction | aspartic-type endopeptidase activity | 4.13e-11 | 37 | 35 | 6 | GO:0004190 | |
| GeneOntologyMolecularFunction | aspartic-type peptidase activity | 4.89e-11 | 38 | 35 | 6 | GO:0070001 | |
| GeneOntologyMolecularFunction | RNA stem-loop binding | 2.45e-10 | 21 | 35 | 5 | GO:0035613 | |
| GeneOntologyMolecularFunction | RNA endonuclease activity, producing 5'-phosphomonoesters | 5.14e-09 | 37 | 35 | 5 | GO:0016891 | |
| GeneOntologyMolecularFunction | DNA polymerase activity | 5.91e-09 | 38 | 35 | 5 | GO:0034061 | |
| GeneOntologyMolecularFunction | endonuclease activity, active with either ribo- or deoxyribonucleic acids and producing 5'-phosphomonoesters | 1.60e-08 | 46 | 35 | 5 | GO:0016893 | |
| GeneOntologyMolecularFunction | RNA endonuclease activity | 2.52e-07 | 79 | 35 | 5 | GO:0004521 | |
| GeneOntologyMolecularFunction | RNA nuclease activity | 3.75e-06 | 136 | 35 | 5 | GO:0004540 | |
| GeneOntologyMolecularFunction | endonuclease activity | 3.75e-06 | 136 | 35 | 5 | GO:0004519 | |
| GeneOntologyMolecularFunction | catalytic activity, acting on DNA | 5.68e-06 | 262 | 35 | 6 | GO:0140097 | |
| GeneOntologyMolecularFunction | nucleotidyltransferase activity | 6.46e-06 | 152 | 35 | 5 | GO:0016779 | |
| GeneOntologyMolecularFunction | carnitine O-acyltransferase activity | 4.46e-05 | 6 | 35 | 2 | GO:0016406 | |
| GeneOntologyMolecularFunction | nuclease activity | 4.85e-05 | 231 | 35 | 5 | GO:0004518 | |
| GeneOntologyMolecularFunction | endopeptidase activity | 9.21e-05 | 430 | 35 | 6 | GO:0004175 | |
| GeneOntologyMolecularFunction | structural molecule activity | 1.22e-04 | 891 | 35 | 8 | GO:0005198 | |
| GeneOntologyMolecularFunction | mechanosensitive monoatomic ion channel activity | 4.49e-04 | 18 | 35 | 2 | GO:0008381 | |
| GeneOntologyMolecularFunction | catalytic activity, acting on RNA | 7.51e-04 | 417 | 35 | 5 | GO:0140098 | |
| GeneOntologyMolecularFunction | zinc ion binding | 7.73e-04 | 891 | 35 | 7 | GO:0008270 | |
| GeneOntologyMolecularFunction | catalytic activity, acting on a nucleic acid | 8.10e-04 | 645 | 35 | 6 | GO:0140640 | |
| GeneOntologyMolecularFunction | transition metal ion binding | 8.58e-04 | 1189 | 35 | 8 | GO:0046914 | |
| GeneOntologyMolecularFunction | peptidase activity | 8.70e-04 | 654 | 35 | 6 | GO:0008233 | |
| GeneOntologyMolecularFunction | cytoskeletal motor activity | 1.15e-03 | 118 | 35 | 3 | GO:0003774 | |
| GeneOntologyMolecularFunction | microfilament motor activity | 2.02e-03 | 38 | 35 | 2 | GO:0000146 | |
| GeneOntologyMolecularFunction | ADP binding | 3.20e-03 | 48 | 35 | 2 | GO:0043531 | |
| GeneOntologyMolecularFunction | O-acyltransferase activity | 4.80e-03 | 59 | 35 | 2 | GO:0008374 | |
| GeneOntologyMolecularFunction | actin filament binding | 7.26e-03 | 227 | 35 | 3 | GO:0051015 | |
| GeneOntologyMolecularFunction | actin binding | 9.51e-03 | 479 | 35 | 4 | GO:0003779 | |
| GeneOntologyMolecularFunction | cytoskeletal protein binding | 1.13e-02 | 1099 | 35 | 6 | GO:0008092 | |
| GeneOntologyBiologicalProcess | DNA integration | 1.54e-11 | 13 | 36 | 5 | GO:0015074 | |
| GeneOntologyBiologicalProcess | DNA synthesis involved in DNA repair | 1.97e-08 | 48 | 36 | 5 | GO:0000731 | |
| GeneOntologyBiologicalProcess | RNA-templated DNA biosynthetic process | 3.19e-07 | 83 | 36 | 5 | GO:0006278 | |
| GeneOntologyBiologicalProcess | DNA-templated DNA replication | 1.37e-05 | 178 | 36 | 5 | GO:0006261 | |
| GeneOntologyBiologicalProcess | cell-cell fusion | 1.43e-05 | 85 | 36 | 4 | GO:0140253 | |
| GeneOntologyBiologicalProcess | syncytium formation by plasma membrane fusion | 1.43e-05 | 85 | 36 | 4 | GO:0000768 | |
| GeneOntologyBiologicalProcess | syncytium formation | 1.72e-05 | 89 | 36 | 4 | GO:0006949 | |
| GeneOntologyBiologicalProcess | DNA biosynthetic process | 3.64e-05 | 218 | 36 | 5 | GO:0071897 | |
| GeneOntologyBiologicalProcess | DNA replication | 1.97e-04 | 312 | 36 | 5 | GO:0006260 | |
| GeneOntologyBiologicalProcess | carnitine metabolic process | 2.28e-04 | 13 | 36 | 2 | GO:0009437 | |
| GeneOntologyBiologicalProcess | DNA recombination | 4.21e-04 | 368 | 36 | 5 | GO:0006310 | |
| GeneOntologyBiologicalProcess | amino-acid betaine metabolic process | 4.45e-04 | 18 | 36 | 2 | GO:0006577 | |
| GeneOntologyCellularComponent | myosin complex | 2.81e-06 | 59 | 35 | 4 | GO:0016459 | |
| GeneOntologyCellularComponent | myosin filament | 9.64e-06 | 25 | 35 | 3 | GO:0032982 | |
| GeneOntologyCellularComponent | myosin II complex | 1.37e-05 | 28 | 35 | 3 | GO:0016460 | |
| GeneOntologyCellularComponent | mitochondrial crista | 3.65e-04 | 17 | 35 | 2 | GO:0030061 | |
| GeneOntologyCellularComponent | actomyosin | 9.81e-04 | 117 | 35 | 3 | GO:0042641 | |
| GeneOntologyCellularComponent | brush border | 2.08e-03 | 152 | 35 | 3 | GO:0005903 | |
| HumanPheno | Prune belly | 3.60e-05 | 4 | 13 | 2 | HP:0004392 | |
| Domain | Piezo | 2.33e-06 | 2 | 29 | 2 | IPR027272 | |
| Domain | Piezo_RRas_bdg | 2.33e-06 | 2 | 29 | 2 | PF12166 | |
| Domain | Piezo_dom | 2.33e-06 | 2 | 29 | 2 | IPR031805 | |
| Domain | PIEZO | 2.33e-06 | 2 | 29 | 2 | PF15917 | |
| Domain | Piezo_RRas-bd_dom | 2.33e-06 | 2 | 29 | 2 | IPR031334 | |
| Domain | Myosin_tail_1 | 2.70e-06 | 18 | 29 | 3 | PF01576 | |
| Domain | Myosin_tail | 2.70e-06 | 18 | 29 | 3 | IPR002928 | |
| Domain | Myosin-like_IQ_dom | 3.21e-06 | 19 | 29 | 3 | IPR027401 | |
| Domain | - | 3.21e-06 | 19 | 29 | 3 | 4.10.270.10 | |
| Domain | MYOSIN_MOTOR | 2.74e-05 | 38 | 29 | 3 | PS51456 | |
| Domain | Myosin_head | 2.74e-05 | 38 | 29 | 3 | PF00063 | |
| Domain | Myosin_head_motor_dom | 2.74e-05 | 38 | 29 | 3 | IPR001609 | |
| Domain | MYSc | 2.74e-05 | 38 | 29 | 3 | SM00242 | |
| Domain | Carn_acyltransf | 4.87e-05 | 7 | 29 | 2 | PF00755 | |
| Domain | ACYLTRANSF_C_1 | 4.87e-05 | 7 | 29 | 2 | PS00439 | |
| Domain | Carn_acyl_trans | 4.87e-05 | 7 | 29 | 2 | IPR000542 | |
| Domain | ACYLTRANSF_C_2 | 4.87e-05 | 7 | 29 | 2 | PS00440 | |
| Domain | IQ | 1.79e-04 | 71 | 29 | 3 | PF00612 | |
| Domain | Myosin_N | 2.41e-04 | 15 | 29 | 2 | IPR004009 | |
| Domain | Myosin_N | 2.41e-04 | 15 | 29 | 2 | PF02736 | |
| Domain | IQ | 2.65e-04 | 81 | 29 | 3 | SM00015 | |
| Domain | IQ_motif_EF-hand-BS | 3.61e-04 | 90 | 29 | 3 | IPR000048 | |
| Domain | IQ | 3.98e-04 | 93 | 29 | 3 | PS50096 | |
| Domain | PH | 4.11e-04 | 229 | 29 | 4 | PF00169 | |
| Domain | PH | 8.51e-04 | 278 | 29 | 4 | SM00233 | |
| Domain | PH_DOMAIN | 8.62e-04 | 279 | 29 | 4 | PS50003 | |
| Domain | PH_domain | 8.74e-04 | 280 | 29 | 4 | IPR001849 | |
| Domain | P-loop_NTPase | 1.67e-03 | 848 | 29 | 6 | IPR027417 | |
| Domain | - | 2.97e-03 | 391 | 29 | 4 | 2.30.29.30 | |
| Domain | PH_dom-like | 4.03e-03 | 426 | 29 | 4 | IPR011993 | |
| Domain | Zinc_finger_PHD-type_CS | 4.56e-03 | 65 | 29 | 2 | IPR019786 | |
| Domain | PHD | 6.02e-03 | 75 | 29 | 2 | PF00628 | |
| Domain | Znf_PHD-finger | 6.66e-03 | 79 | 29 | 2 | IPR019787 | |
| Domain | PHD | 8.38e-03 | 89 | 29 | 2 | SM00249 | |
| Domain | Znf_PHD | 8.75e-03 | 91 | 29 | 2 | IPR001965 | |
| Domain | ZF_PHD_2 | 9.51e-03 | 95 | 29 | 2 | PS50016 | |
| Domain | ZF_PHD_1 | 9.70e-03 | 96 | 29 | 2 | PS01359 | |
| Pathway | REACTOME_RHO_GTPASES_ACTIVATE_ROCKS | 2.60e-04 | 19 | 18 | 2 | M27493 | |
| Pathway | REACTOME_RHO_GTPASES_ACTIVATE_CIT | 2.60e-04 | 19 | 18 | 2 | M27489 | |
| Pathway | REACTOME_SEMA4D_INDUCED_CELL_MIGRATION_AND_GROWTH_CONE_COLLAPSE | 2.89e-04 | 20 | 18 | 2 | M18415 | |
| Pathway | REACTOME_RHO_GTPASES_ACTIVATE_PAKS | 3.19e-04 | 21 | 18 | 2 | M27494 | |
| Pathway | REACTOME_RHO_GTPASES_ACTIVATE_PAKS | 3.83e-04 | 23 | 18 | 2 | MM15222 | |
| Pathway | REACTOME_SEMA4D_IN_SEMAPHORIN_SIGNALING | 4.18e-04 | 24 | 18 | 2 | M2243 | |
| Pathway | REACTOME_EPHA_MEDIATED_GROWTH_CONE_COLLAPSE | 6.13e-04 | 29 | 18 | 2 | M27309 | |
| Pubmed | A revised nomenclature for transcribed human endogenous retroviral loci. | 6.57e-12 | 94 | 36 | 7 | 21542922 | |
| Pubmed | 4.07e-09 | 4 | 36 | 3 | 7983737 | ||
| Pubmed | Many human endogenous retrovirus K (HERV-K) proviruses are unique to humans. | 4.07e-09 | 4 | 36 | 3 | 10469592 | |
| Pubmed | Quantitation of HERV-K env gene expression and splicing in human breast cancer. | 1.02e-08 | 5 | 36 | 3 | 12629516 | |
| Pubmed | 2.23e-07 | 12 | 36 | 3 | 14557543 | ||
| Pubmed | 8.22e-07 | 18 | 36 | 3 | 18664271 | ||
| Pubmed | 1.04e-06 | 2 | 36 | 2 | 30324494 | ||
| Pubmed | [Feeling the pressure? Identification of two proteins activated by mechanical forces]. | 1.04e-06 | 2 | 36 | 2 | 21299953 | |
| Pubmed | 1.04e-06 | 2 | 36 | 2 | 21056836 | ||
| Pubmed | 1.04e-06 | 2 | 36 | 2 | 30745454 | ||
| Pubmed | The role of PIEZO ion channels in the musculoskeletal system. | 1.04e-06 | 2 | 36 | 2 | 36717101 | |
| Pubmed | Piezo1 expression in chondrocytes controls endochondral ossification and osteoarthritis development. | 1.04e-06 | 2 | 36 | 2 | 38395992 | |
| Pubmed | 1.04e-06 | 2 | 36 | 2 | 37820892 | ||
| Pubmed | Astrocytes in the optic nerve head express putative mechanosensitive channels. | 1.04e-06 | 2 | 36 | 2 | 26236150 | |
| Pubmed | Touch, Tension, and Transduction - The Function and Regulation of Piezo Ion Channels. | 1.04e-06 | 2 | 36 | 2 | 27743844 | |
| Pubmed | Axonal and Glial PIEZO1 and PIEZO2 Immunoreactivity in Human Clitoral Krause's Corpuscles. | 1.04e-06 | 2 | 36 | 2 | 38928429 | |
| Pubmed | Mechanisms of mechanotransduction and physiological roles of PIEZO channels. | 1.04e-06 | 2 | 36 | 2 | 39251883 | |
| Pubmed | 1.04e-06 | 2 | 36 | 2 | 30628892 | ||
| Pubmed | Piezo1 ion channel pore properties are dictated by C-terminal region. | 1.04e-06 | 2 | 36 | 2 | 26008989 | |
| Pubmed | 1.04e-06 | 2 | 36 | 2 | 37975162 | ||
| Pubmed | Piezo1 and Piezo2 are essential components of distinct mechanically activated cation channels. | 1.04e-06 | 2 | 36 | 2 | 20813920 | |
| Pubmed | 1.04e-06 | 2 | 36 | 2 | 9060628 | ||
| Pubmed | Transduction of Repetitive Mechanical Stimuli by Piezo1 and Piezo2 Ion Channels. | 1.04e-06 | 2 | 36 | 2 | 28636944 | |
| Pubmed | A Plug-and-Latch Mechanism for Gating the Mechanosensitive Piezo Channel. | 1.04e-06 | 2 | 36 | 2 | 32142647 | |
| Pubmed | Evolutionary relationships within a subgroup of HERV-K-related human endogenous retroviruses. | 1.04e-06 | 2 | 36 | 2 | 9460924 | |
| Pubmed | 1.04e-06 | 2 | 36 | 2 | 34464353 | ||
| Pubmed | 1.04e-06 | 2 | 36 | 2 | 27824130 | ||
| Pubmed | 1.04e-06 | 2 | 36 | 2 | 25037583 | ||
| Pubmed | 3.12e-06 | 3 | 36 | 2 | 38124148 | ||
| Pubmed | 3.12e-06 | 3 | 36 | 2 | 29521261 | ||
| Pubmed | PIEZOs mediate neuronal sensing of blood pressure and the baroreceptor reflex. | 3.12e-06 | 3 | 36 | 2 | 30361375 | |
| Pubmed | Piezo1, a mechanically activated ion channel, is required for vascular development in mice. | 3.12e-06 | 3 | 36 | 2 | 24958852 | |
| Pubmed | 3.12e-06 | 3 | 36 | 2 | 10516026 | ||
| Pubmed | 3.12e-06 | 3 | 36 | 2 | 37321223 | ||
| Pubmed | Functional and Molecular Characterization of Mechanoinsensitive "Silent" Nociceptors. | 3.12e-06 | 3 | 36 | 2 | 29241539 | |
| Pubmed | 3.12e-06 | 3 | 36 | 2 | 9971820 | ||
| Pubmed | 3.12e-06 | 3 | 36 | 2 | 30726728 | ||
| Pubmed | 3.12e-06 | 3 | 36 | 2 | 35650194 | ||
| Pubmed | Mechanosensory hair cells express two molecularly distinct mechanotransduction channels. | 6.24e-06 | 4 | 36 | 2 | 27893727 | |
| Pubmed | 6.24e-06 | 4 | 36 | 2 | 36563677 | ||
| Pubmed | 6.24e-06 | 4 | 36 | 2 | 29932067 | ||
| Pubmed | Piezo mechanosensory channels regulate centrosome integrity and mitotic entry. | 6.24e-06 | 4 | 36 | 2 | 36574677 | |
| Pubmed | 1.04e-05 | 5 | 36 | 2 | 34852225 | ||
| Pubmed | Transcriptionally active HERV-K genes: identification, isolation, and chromosomal mapping. | 1.04e-05 | 5 | 36 | 2 | 11401426 | |
| Pubmed | Mechanosensitive brain tumor cells construct blood-tumor barrier to mask chemosensitivity. | 1.04e-05 | 5 | 36 | 2 | 36323321 | |
| Pubmed | Telokin expression is restricted to smooth muscle tissues during mouse development. | 1.04e-05 | 5 | 36 | 2 | 11121372 | |
| Pubmed | 1.40e-05 | 45 | 36 | 3 | 22114352 | ||
| Pubmed | 1.56e-05 | 6 | 36 | 2 | 11001805 | ||
| Pubmed | 1.56e-05 | 6 | 36 | 2 | 15063128 | ||
| Pubmed | 2.07e-05 | 1168 | 36 | 8 | 19946888 | ||
| Pubmed | Perivascular neurons instruct 3D vascular lattice formation via neurovascular contact. | 2.18e-05 | 7 | 36 | 2 | 38733989 | |
| Pubmed | 2.74e-05 | 1215 | 36 | 8 | 15146197 | ||
| Pubmed | The Piezo channel is a mechano-sensitive complex component in the mammalian inner ear hair cell. | 2.91e-05 | 8 | 36 | 2 | 38228630 | |
| Pubmed | Evidence for the involvement of ASIC3 in sensory mechanotransduction in proprioceptors. | 2.91e-05 | 8 | 36 | 2 | 27161260 | |
| Pubmed | Piezo1 and Piezo2 collectively regulate jawbone development. | 2.91e-05 | 8 | 36 | 2 | 38619396 | |
| Pubmed | 2.91e-05 | 8 | 36 | 2 | 33424621 | ||
| Pubmed | 2.91e-05 | 8 | 36 | 2 | 34112781 | ||
| Pubmed | 4.66e-05 | 10 | 36 | 2 | 12970426 | ||
| Pubmed | 5.62e-05 | 202 | 36 | 4 | 24639526 | ||
| Pubmed | The DNA sequence and comparative analysis of human chromosome 5. | 6.53e-05 | 75 | 36 | 3 | 15372022 | |
| Pubmed | 6.83e-05 | 12 | 36 | 2 | 8424456 | ||
| Pubmed | 8.84e-05 | 83 | 36 | 3 | 9039502 | ||
| Pubmed | 9.77e-05 | 233 | 36 | 4 | 29518331 | ||
| Pubmed | 1.24e-04 | 16 | 36 | 2 | 38448588 | ||
| Pubmed | 1.49e-04 | 99 | 36 | 3 | 31723608 | ||
| Pubmed | ESCPE-1 mediates retrograde endosomal sorting of the SARS-CoV-2 host factor Neuropilin-1. | 2.00e-04 | 1201 | 36 | 7 | 35696571 | |
| Pubmed | Interactome Analysis of Human Phospholipase D and Phosphatidic Acid-Associated Protein Network. | 2.03e-04 | 282 | 36 | 4 | 35007762 | |
| Pubmed | 2.28e-04 | 542 | 36 | 5 | 14651853 | ||
| Pubmed | 2.83e-04 | 24 | 36 | 2 | 32186512 | ||
| Pubmed | 2.98e-04 | 312 | 36 | 4 | 37120454 | ||
| Pubmed | 3.08e-04 | 25 | 36 | 2 | 38588611 | ||
| Pubmed | NDP52 interacts with mitochondrial RNA poly(A) polymerase to promote mitophagy. | 3.08e-04 | 25 | 36 | 2 | 30309841 | |
| Pubmed | Genetic variants in nuclear-encoded mitochondrial genes influence AIDS progression. | 3.45e-04 | 926 | 36 | 6 | 20877624 | |
| Pubmed | 3.56e-04 | 327 | 36 | 4 | 31409639 | ||
| Pubmed | HIV-1 Vpr modulates macrophage metabolic pathways: a SILAC-based quantitative analysis. | 3.72e-04 | 135 | 36 | 3 | 23874603 | |
| Pubmed | DCAF8, a novel MuRF1 interaction partner, promotes muscle atrophy. | 5.34e-04 | 364 | 36 | 4 | 31391242 | |
| Pubmed | A mitochondrial protein compendium elucidates complex I disease biology. | 6.60e-04 | 1047 | 36 | 6 | 18614015 | |
| Pubmed | Identification of rare DNA variants in mitochondrial disorders with improved array-based sequencing. | 6.78e-04 | 37 | 36 | 2 | 20843780 | |
| Pubmed | Proteomic analysis of the mouse liver mitochondrial inner membrane. | 7.91e-04 | 175 | 36 | 3 | 12865426 | |
| Pubmed | MITOL regulates phosphatidic acid-binding activity of RMDN3/PTPIP51. | 8.33e-04 | 41 | 36 | 2 | 34964862 | |
| Pubmed | 8.57e-04 | 725 | 36 | 5 | 27025967 | ||
| Pubmed | 9.00e-04 | 733 | 36 | 5 | 34672954 | ||
| Pubmed | 9.59e-04 | 44 | 36 | 2 | 35293971 | ||
| Pubmed | 1.02e-03 | 191 | 36 | 3 | 33762435 | ||
| Pubmed | 1.02e-03 | 1139 | 36 | 6 | 36417873 | ||
| Interaction | DSTN interactions | 4.37e-07 | 187 | 32 | 6 | int:DSTN | |
| Interaction | PLD6 interactions | 3.78e-06 | 151 | 32 | 5 | int:PLD6 | |
| Interaction | PPP5D1P interactions | 1.46e-05 | 4 | 32 | 2 | int:PPP5D1P | |
| Interaction | CLEC4D interactions | 5.30e-05 | 261 | 32 | 5 | int:CLEC4D | |
| Interaction | LGR4 interactions | 5.40e-05 | 262 | 32 | 5 | int:LGR4 | |
| Cytoband | 16q24.3 | 7.31e-04 | 52 | 35 | 2 | 16q24.3 | |
| GeneFamily | Myosin heavy chains | 2.57e-07 | 15 | 16 | 3 | 1098 | |
| GeneFamily | Pleckstrin homology domain containing|Rho guanine nucleotide exchange factors|C2 domain containing | 7.32e-04 | 206 | 16 | 3 | 682 | |
| GeneFamily | PHD finger proteins | 2.81e-03 | 90 | 16 | 2 | 88 | |
| ToppCell | facs-Large_Intestine-Proximal-3m-Epithelial|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.65e-06 | 173 | 29 | 4 | e1378201b15ffb98e196ac39fe3ee4b4078953bd | |
| ToppCell | facs-Large_Intestine-Proximal-3m|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.65e-06 | 173 | 29 | 4 | 99532bb768ee35fed939a377acb5215d3f8904bd | |
| ToppCell | TCGA-Stomach-Primary_Tumor-Stomach_Adenocarcinoma-Stomach_Adenocarcinoma_-_NOS-6|TCGA-Stomach / Sample_Type by Project: Shred V9 | 7.02e-06 | 192 | 29 | 4 | 4e689bca7a242f8482e25f273656e2caba8821c0 | |
| ToppCell | 367C-Myeloid-Macrophage-SPP1+_Macrophage_2|367C / Donor, Lineage, Cell class and subclass (all cells) | 1.04e-04 | 141 | 29 | 3 | e409da87da5a38ba4d0ccc5e3f8bd89f480f9dab | |
| ToppCell | 367C-Myeloid-Macrophage-SPP1+_Macrophage_2|Myeloid / Donor, Lineage, Cell class and subclass (all cells) | 1.10e-04 | 144 | 29 | 3 | 3ba7f8bd6d1c551048403c94693d63e60f7cbbb7 | |
| ToppCell | 367C-Myeloid-Macrophage-SPP1+_Macrophage_2|Macrophage / Donor, Lineage, Cell class and subclass (all cells) | 1.10e-04 | 144 | 29 | 3 | 38ff324366ad5be626e3657c1e33277fc36ddd4c | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-vascular_smooth_muscle_cell-D062|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 1.59e-04 | 163 | 29 | 3 | 51dee6c21cbeca4e17d1cc386e203f0c403089e8 | |
| ToppCell | Bronchial_Biopsy-Immune-Mast_cells|Bronchial_Biopsy / Tissue, Lineage and Cell class of Lung Cells from 10X | 1.86e-04 | 172 | 29 | 3 | c477008444d2d71071177807870d7455e90c2fad | |
| ToppCell | lymphoid-B_cell-pro-B|B_cell / Lineage, cell class and subclass | 1.86e-04 | 172 | 29 | 3 | da1e2e54f442f5c2032c857c4812e9060f2053cd | |
| ToppCell | facs-Lung-EPCAM-3m-Myeloid-dendritic_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.03e-04 | 177 | 29 | 3 | d445167dae956e641386f84ab3ae9f47c089e09a | |
| ToppCell | facs-Lung-EPCAM-3m-Myeloid-Ccr7+_Dendritic|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.06e-04 | 178 | 29 | 3 | 0b456ac768e026c3ecd5a9a4f43d6f126e7685a1 | |
| ToppCell | TCGA-Skin-Metastatic-Melanoma-Skin_Cutaneous_Melanoma-2|TCGA-Skin / Sample_Type by Project: Shred V9 | 2.17e-04 | 181 | 29 | 3 | 9d5b331cabc5524f0a9fd8b571e87be4c447c7d4 | |
| ToppCell | facs-Skin-nan-18m-Epithelial-epidermal_cell|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.27e-04 | 184 | 29 | 3 | dc7f6ee4062856a02423fff8b1cce62d46a9355c | |
| ToppCell | 21-Trachea-Mesenchymal-Airway_Smooth_Muscle|Trachea / Age, Tissue, Lineage and Cell class | 2.27e-04 | 184 | 29 | 3 | 86a96cd88e50eacad1f0badfbbf6dc626f41725e | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell_/_Pericyte|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 2.31e-04 | 185 | 29 | 3 | 7092436b4db90289516ed130ade596e3021cffaf | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell_/_Pericyte|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.31e-04 | 185 | 29 | 3 | 51dfe6ac7df8b330343b37e3bee71e5c65267189 | |
| ToppCell | LPS_only|World / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.31e-04 | 185 | 29 | 3 | a72ccb147ca505880e2da8f6a70b9d570464a691 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell_/_Pericyte-|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.31e-04 | 185 | 29 | 3 | a8c02cec3c414f3a0da9f2d6d28ce563b0030705 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell_/_Pericyte-|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 2.31e-04 | 185 | 29 | 3 | a8ca7819066d5297ef6966e7f3e2c9f8a7673fdc | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-pericyte_cell-D150|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 2.38e-04 | 187 | 29 | 3 | fa01a61bfd13feb033ba1e35cf513707b1bff8c8 | |
| ToppCell | facs-Pancreas-Endocrine-3m-Endothelial|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.42e-04 | 188 | 29 | 3 | da862ea3c74f42d0dbae38b09211a45c593d477e | |
| ToppCell | facs-Pancreas-Endocrine-3m-Endothelial-nan|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.42e-04 | 188 | 29 | 3 | b82a7667ef74a05e8bc744f6c090a7cc7b8efe32 | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-pericyte_cell-D062|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 2.42e-04 | 188 | 29 | 3 | ccddc08121caff958a2b6f9e278a018858af6b4d | |
| ToppCell | facs-Pancreas-Endocrine-3m-Endothelial-endothelial_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.42e-04 | 188 | 29 | 3 | 19672d284fe89c9c3c7697514ca1f659329c34f4 | |
| ToppCell | PCW_13-14-Mesenchymal-Mesenchymal_myocytic-mes_immature_ASM2_(12)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 2.46e-04 | 189 | 29 | 3 | 0abc7a4900cc9033bc1be69b770ccc54a6bf41b4 | |
| ToppCell | E12.5-Epithelial-epithelial_progenitor_cell-epithelial_unknown_3|E12.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 2.46e-04 | 189 | 29 | 3 | 620d30bb6211fff6adab0638d0d994f547167a29 | |
| ToppCell | 3'-Broncho-tracheal-Immune_Myeloid-Myeloid_macrophage-elicited_macrophage-Monocyte-derived_macrophage-Monocyte-derived_macrophage_L.1.2.3.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.54e-04 | 191 | 29 | 3 | 0b296404ebad0aadb75737f8c0462ec6934fc8bb | |
| ToppCell | Fetal_brain-fetalBrain_Zhong_nature-GW16-OPC_related-OPC|GW16 / Sample Type, Dataset, Time_group, and Cell type. | 2.58e-04 | 192 | 29 | 3 | 5d9bc234f01c73b2531edf8960588d5b6cf260a7 | |
| ToppCell | Fetal_brain-fetalBrain_Zhong_nature-GW16-OPC_related|GW16 / Sample Type, Dataset, Time_group, and Cell type. | 2.58e-04 | 192 | 29 | 3 | e6d115143ced6a0d9fe7c98acd3f730bac83f66b | |
| ToppCell | PCW_13-14-Mesenchymal-Mesenchymal_myocytic-mes_pericyte_(14)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 2.58e-04 | 192 | 29 | 3 | 55f95454399fd533df75db06584eaa48d6ee3830 | |
| ToppCell | PCW_10-12-Mesenchymal-Mesenchymal_myocytic-mes_pericyte_(14)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 2.58e-04 | 192 | 29 | 3 | 5000440dc1ed17e7474d340921bdff945646f27e | |
| ToppCell | PCW_13-14-Mesenchymal-Mesenchymal_myocytic|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 2.62e-04 | 193 | 29 | 3 | 000b9e6a819b94ea2e6e9173daf97ba9ac2b6cc6 | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Vascular-Mural_cell-SMC_prolif-G|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 2.66e-04 | 194 | 29 | 3 | 78dcb9d48259afabe73b41c5508a73a8d62339a4 | |
| ToppCell | RA-03._Atrial_Cardiomyocyte|World / Chamber and Cluster_Paper | 2.66e-04 | 194 | 29 | 3 | 89812fb164065041357bb37a3c2d87028ec3de4e | |
| ToppCell | 11.5-Distal-Mesenchymal-Pericyte|Distal / Age, Tissue, Lineage and Cell class | 2.66e-04 | 194 | 29 | 3 | 08701590496cf85ff790e54a81493c61177e76ff | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Vascular-Mural_cell-Pericyte-G|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 2.70e-04 | 195 | 29 | 3 | d760d1423f9a8a373fe7b250ea9b1d67a0c0059f | |
| ToppCell | PND01-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_vascular|PND01 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.74e-04 | 196 | 29 | 3 | 6708026bafd19c35c5c4e81911344d36a0f508cd | |
| ToppCell | kidney_cells-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell_/_Pericyte|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.78e-04 | 197 | 29 | 3 | bc6c530330907a5ec823cc243c8e9c9e340cfb9c | |
| ToppCell | 356C-Fibroblasts-Fibroblast-K_(Pericytes)|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells) | 2.78e-04 | 197 | 29 | 3 | 71367bebc23d0e81f60f780d6b0ab3a1783ac014 | |
| ToppCell | 356C-Fibroblasts-Fibroblast-K_(Pericytes)-|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells) | 2.78e-04 | 197 | 29 | 3 | 0f9836554ace3f9d155ebafdd719aa26466ca44e | |
| ToppCell | kidney_cells-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell_/_Pericyte-|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.78e-04 | 197 | 29 | 3 | 77fe092aae8f05fe137680506892d2f61071d6ea | |
| ToppCell | (02)_MMP9/10+|World / shred by cell type by condition | 2.86e-04 | 199 | 29 | 3 | 3f78eddeaa67d3b767aa38de765632166b09a4f0 | |
| ToppCell | Tracheal-10x3prime_v2-Stromal-Schwann|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 2.86e-04 | 199 | 29 | 3 | 8dc65662c3ca1db2ba0091332f0658abc0afc5de | |
| ToppCell | Tracheal-10x3prime_v2-Stromal-Schwann-Schwann_nonmyelinating|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 2.86e-04 | 199 | 29 | 3 | a92718a3f1153b8d2196fd343ed5bc0ebc98cad7 | |
| ToppCell | LPS_anti-TNF-Mesenchymal_myocytic-Pericyte-Pericyte_2|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 2.90e-04 | 200 | 29 | 3 | 786f1ae53e60b5ffbf4bfd393d10b802478148b3 | |
| ToppCell | mLN-Dendritic_cell-cDC2|Dendritic_cell / Region, Cell class and subclass | 2.90e-04 | 200 | 29 | 3 | e3f7852aaa26a9b3e626d85e40afde799e873045 | |
| Drug | S-(-)-Etomoxir | 1.93e-07 | 100 | 30 | 5 | CID000060765 | |
| Drug | formycin triphosphate | 4.12e-05 | 51 | 30 | 3 | CID000122274 | |
| Drug | purealin | 6.07e-05 | 58 | 30 | 3 | CID006419303 | |
| Drug | L-Carnitine | 9.16e-05 | 11 | 30 | 2 | DB00583 | |
| Drug | 17-AAG; Down 200; 1uM; HL60; HT_HG-U133A | 1.06e-04 | 189 | 30 | 4 | 1159_DN | |
| Drug | etomoxiryl-CoA | 1.10e-04 | 12 | 30 | 2 | CID003081714 | |
| Drug | LY 294002; Down 200; 10uM; HL60; HT_HG-U133A | 1.13e-04 | 192 | 30 | 4 | 2699_DN | |
| Drug | Butoconazole nitrate [32872-77-1]; Down 200; 8.4uM; HL60; HT_HG-U133A | 1.18e-04 | 194 | 30 | 4 | 2427_DN | |
| Drug | Furaltadone hydrochloride [3759-92-0]; Down 200; 11uM; MCF7; HT_HG-U133A | 1.18e-04 | 194 | 30 | 4 | 3932_DN | |
| Drug | Amitryptiline hydrochloride [549-18-8]; Down 200; 12.8uM; PC3; HT_HG-U133A | 1.20e-04 | 195 | 30 | 4 | 1823_DN | |
| Drug | 3-Acetamidocoumarin [779-30-6]; Down 200; 19.6uM; HL60; HT_HG-U133A | 1.22e-04 | 196 | 30 | 4 | 2941_DN | |
| Drug | Prilocaine hydrochloride [1786-81-8]; Down 200; 15.6uM; MCF7; HT_HG-U133A | 1.22e-04 | 196 | 30 | 4 | 4749_DN | |
| Drug | Epicatechin-(-) [154-23-4]; Down 200; 13.8uM; HL60; HT_HG-U133A | 1.22e-04 | 196 | 30 | 4 | 2160_DN | |
| Drug | Guanadrel sulfate [22195-34-2]; Up 200; 7.6uM; MCF7; HT_HG-U133A | 1.25e-04 | 197 | 30 | 4 | 3438_UP | |
| Drug | Pronethalol hydrochloride [51-02-5]; Down 200; 15uM; HL60; HT_HG-U133A | 1.25e-04 | 197 | 30 | 4 | 2902_DN | |
| Drug | Clindamycin hydrochloride [21462-39-5]; Down 200; 8.6uM; PC3; HT_HG-U133A | 1.25e-04 | 197 | 30 | 4 | 5815_DN | |
| Drug | iloprost; Up 200; 1uM; MCF7; HG-U133A | 1.27e-04 | 198 | 30 | 4 | 427_UP | |
| Drug | Halcinonide [3093-35-4]; Down 200; 8.8uM; PC3; HT_HG-U133A | 1.27e-04 | 198 | 30 | 4 | 3680_DN | |
| Drug | chlorpromazine hydrochloride; Down 200; 1uM; MCF7; HT_HG-U133A_EA | 1.30e-04 | 199 | 30 | 4 | 1055_DN | |
| Drug | Mefenamic acid [61-68-7]; Down 200; 16.6uM; MCF7; HT_HG-U133A | 1.30e-04 | 199 | 30 | 4 | 5534_DN | |
| Drug | Beta-Escin [11072-93-8]; Down 200; 3.2uM; MCF7; HT_HG-U133A | 1.32e-04 | 200 | 30 | 4 | 4364_DN | |
| Disease | energy expenditure | 3.45e-04 | 27 | 30 | 2 | EFO_0005109 | |
| Disease | fatty liver disease (biomarker_via_orthology) | 5.17e-04 | 33 | 30 | 2 | DOID:9452 (biomarker_via_orthology) |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| PKDKRQKAWNWWNLN | 561 | Q5W0A0 | |
| MLALLGWWWFFSRKK | 16 | Q92667 | |
| WLKQIWNDYKLKWNP | 86 | P32297 | |
| LVWKNWLGVKRQPLW | 11 | Q86UK0 | |
| KKWWEFKQGSVKNWV | 251 | Q7LC44 | |
| FLWRKKWLGQWAKQL | 181 | Q8N4X5 | |
| RLQWYLKLKSWWATN | 216 | P50416 | |
| GYLWAIGKNVWKRWK | 526 | Q9ULU8 | |
| SAITKWNWNWAKLLP | 1206 | Q8IV33 | |
| KKNKGVKDWPWWKLF | 1226 | Q92614 | |
| KLIWWKDNKNKTWEI | 811 | P63132 | |
| VWWKNKPKWLLQGIF | 476 | Q01650 | |
| KLRNWQWWRLFTKVK | 821 | P35579 | |
| WQDIRWKNKFWGKSM | 691 | Q9BZF3 | |
| KLIWWKDNKNKTWEI | 811 | P63135 | |
| KLIWWKDNKNKTWEI | 811 | Q9BXR3 | |
| LLNFLGLWSWICKKW | 21 | Q9H8H3 | |
| WKKRWLYWKNRTQEQ | 771 | O60313 | |
| WTTNGNKKIWWIIRG | 331 | O95838 | |
| LGWQRKQVNWKACRW | 21 | Q96RP9 | |
| LERAKGKRNWLEEWW | 71 | Q9UKG9 | |
| WWKGSKLDCNAKQWR | 151 | Q96GQ5 | |
| WGKKPWSRKKKILWQ | 336 | Q6ZMZ0 | |
| LKRWKKNWFDLWSDG | 16 | Q96CS7 | |
| WGRAWPWKQILKELD | 181 | Q9UK53 | |
| WVAWLWNDPVLRKKY | 276 | Q9NWW5 | |
| YLKLRNWQWWRLFTK | 826 | P35749 | |
| NWQWWRLFTKVKPLL | 831 | P35749 | |
| IWWKDNKNKTWEIGK | 811 | P63136 | |
| VWSQDKWKGKFEVKW | 491 | Q7Z739 | |
| KLIWWKDNKNKTWEI | 811 | P10266 | |
| KLIWWKDNKNKTWEI | 811 | P63133 | |
| QKAKGKKKQWWRPWV | 1526 | Q9H5I5 | |
| KLIWWKDNKNKTWEI | 811 | Q9UQG0 | |
| KQIVWVKLGNYRWWP | 961 | Q9BZ95 | |
| LRFWGWWKLYNKVKP | 16 | Q9H6N6 | |
| RPRKAWAWRLWQLKA | 481 | P51687 | |
| LWRKLLKAFWWLVVA | 621 | Q92508 | |
| IWWKDNKNKTWEIGK | 816 | Q9WJR5 |